Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-069633
Filing Date
2025-05-12
Accepted
2025-05-12 20:56:01
Documents
1
Period of Report
2025-05-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4033
  Complete submission text file 0000950170-25-069633.txt   5458
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Issuer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)

Mailing Address 500 CAPITOL MALL, SUITE 2350 SACRAMENTO CA 95814
Business Address
Kawakami Mark (Reporting) CIK: 0002030709 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37383 | Film No.: 25936796